The Mosaic Company — 5.15/10

PASS / AVOID
NYSE: MOS  |  Oligopolistic crop-nutrient franchise — largest US phosphate producer (~50% share) and Canpotex potash co-owner — trading at a deep discount (~2.9x forward EV/EBITDA, below book value). But margins are collapsing (gross margin 7.9% in Q1'26, −1,072 bps YoY), operating earnings turned negative (−$372.9M), and free cash flow is deeply negative (FY2025 −$535M). Management has missed its flagship phosphate-production and FCF commitments and withdrew guidance. Quality gate: TWO NO (negative FCF, weak track record) — Below Quality Bar, requires an exceptional catalyst.
Financial Trends
3/10
Margins collapsing, FCF negative | Down-cycle
Oligopoly
PASS
Canpotex potash + ~50% US phosphate | Durable
Free Cash Flow
Negative
FY25 −$535M, Q1'26 −$253M | Deteriorating
Quality Gate
2 NO
Below Quality Bar | Needs catalyst
Company overview

The Mosaic Company is a pure-play crop-nutrient producer operating three segments: Phosphates, Potash, and Mosaic Fertilizantes (Brazil distribution and production). Its theme is global food security and fertilizer affordability — a structurally slow-growing (~2-3%/yr volume), highly price-cyclical business. Mosaic is the largest US phosphate producer (~50% of US finished output, ~16% of world) and one of only two Western potash producers that jointly own Canpotex, the export syndicate controlling ~13M tonnes/yr to ~40 countries.

The core tension: a genuinely oligopolistic, hard-to-replicate franchise undermined by a deteriorating financial profile. Revenue grew +14.4% YoY in Q1'26, but that is volume/price-cycle noise masking a sharp margin collapse — consolidated gross margin fell to 7.9% (−1,072 bps YoY), Phosphate segment EBITDA more than halved to $115M, operating earnings swung to a −$372.9M loss, and free cash flow is firmly negative (FY2025 −$535M) with long-term debt up +27% in 2025. Two of the three quality-gate questions are NO (negative FCF, weak management track record), capping the maximum composite at 5.5. The computed composite of 5.15 sits just under that cap — a watch-list, event-driven name, not a quality compounder.

CEO Bruce Bodine (since 2023) Revenue Growth Cyclical / choppy (+14.4% Q1'26)
Segments Phosphate / Potash / Brazil FCF Trajectory Negative (−$535M FY25)
Moat / Oligopoly Canpotex + ~50% US phosphate FYE December 31
Quality Gate TWO NO — Below Bar Margin Trend Collapsing

Score breakdown
3
/ 10
Financial Trends Weight: 25% | Contribution: 0.75
Down-cycle commodity profile. Revenue +14.4% YoY in Q1'26 is volume/price noise; gross margin collapsed to 7.9% (−1,072 bps YoY), operating earnings turned to a −$372.9M loss, and FCF is deeply negative (FY25 −$535M, Q1'26 −$253M). Debt +27% in 2025. Declining share count the lone positive. Mandatory penalties: negative FCF (−2), revenue up / operating income down (−1).
7
/ 10
Thematic Exposure Weight: 35% | Contribution: 2.45
Clears the oligopoly hard gate decisively — largest US phosphate producer (~50%, capacity greater than the next two combined) and one of two Western potash players co-owning Canpotex (top-5 control ~80% globally). Irreplaceable reserve assets, no 12-month customer switching risk. Held to 7 because Mosaic is a price-taker on commodity benchmarks in a slow-growing, intensely cyclical theme.
3
/ 10
Management Quality Weight: 20% | Contribution: 0.60
~50% promise hit rate, with the misses concentrated in the hard commitments (phosphate production normalization, unit-cost targets, FCF coverage) and the hits in softer self-defined targets. Three live red flags: CFO change (Dec 2024), Q1'26 withdrawal of FY phosphate-production and Q2 Fertilizantes EBITDA guidance, and revenue-up / FCF-down. A candid, coherent team that has not earned the benefit of the doubt.
6
/ 10
Investor Sentiment (Inverted) Weight: 5% | Contribution: 0.30
Favorable inverted setup: skeptical street (Hold consensus, JPM Underweight, downward revisions, EPS modeled to trough in 2026), low retail attention, and management repeating a specific phosphate-tightness thesis the street discounts. But it is a macro/commodity call not a company-specific edge, management's near-term credibility is impaired, and capex cuts/layoffs signal defensive preservation — capping it at 6.
7
/ 10
Concerns / Catalysts / Risks Weight: 15% | Contribution: 1.05
A deeply de-rated cyclical: ~2.9x forward EV/EBITDA vs ~6-8x peers, below book value. Real, identifiable catalysts (phosphate structural tightness + China export ban, record Canpotex pace, self-help capital discipline). Low/favorable China exposure. But the key catalyst (sulfur normalization) is event-dependent on an uncontrollable geopolitical resolution, and guidance was withdrawn after a major EPS miss — keeping it short of the top band.
Dimension Score Weight Weighted
Financial Trends 3 25% 0.75
Thematic Exposure 7 35% 2.45
Management Quality 3 20% 0.60
Investor Sentiment (Inverted) 6 5% 0.30
Concerns / Catalysts / Risks 7 15% 1.05
Composite 100% 5.15

Summary thesis

A genuinely oligopolistic, hard-to-replicate crop-nutrient franchise — dominant US phosphate producer and Canpotex potash co-owner — trading at a deep discount (~2.9x forward EV/EBITDA, below book value). But it carries the two disqualifying weaknesses the quality bar is designed to catch: free cash flow is negative and deteriorating (FY2025 −$535M, Q1'26 −$253M) and management has missed its flagship multi-year operational and FCF commitments while withdrawing guidance. Composite 5.15/10.

Quality gate: TWO NO. oligopoly YES; positiveGrowingFcf NO; managementTrackRecord NO. Two NO caps the maximum composite at 5.5 — the computed 5.15 is below the cap (non-binding), but the flag stands: Below Quality Bar — Requires Exceptional Catalyst.


Positioning

The strength is structural: irreplaceable Florida/Louisiana phosphate rock and Saskatchewan potash reserves, vertical integration, and the Canpotex export channel create a real cost-and-channel moat that customers cannot replace within 12 months. Thematic Exposure scores 7/10 and the name is deeply de-rated (below book), which lifts the Concerns/Catalysts dimension to 7/10.

The binding constraints are the financials and the operator. Financial Trends score 3/10 — a margin collapse (gross margin 7.9%, −1,072 bps YoY), a −$372.9M operating loss, and negative FCF define a down-cycle commodity, not a compounder. Management Quality scores 3/10 on a ~50% hit rate skewed toward soft promises, a CFO change, and withdrawn guidance. Mosaic is a price-taker on commodity benchmarks, so the recovery thesis rests on a phosphate-margin snap-back the street is underwriting conservatively — and on a sulfur-cost normalization that depends on a geopolitical resolution the company cannot control.

Per "you don't have to own mediocre companies," MOS is a watch-list, event-driven name — it would earn capital only on a confirmed, durable phosphate-margin recovery, the exceptional catalyst the gate flag demands.


Data sourced from Daloopa (company_id: 492) and FMP (market/valuation/consensus). Analysis date: 2026-06-29. Price $22.43.